Knockdown of TMEPAI in TNBC led to robust inhibition of in vivo tumor growth accompanied by reduced VEGF and HIF1α tumor promoters and enhanced levels of PTEN and p27 tumor suppressors [200]. The gene discussed is VEGFA; the disease is neoplasm.